...
首页> 外文期刊>The Open Process Chemistry Journal >Developing a Commercially Viable Process for an Active Pharmaceutical Ingredient, Challenges, Myths and Reality in the Art of Process Chemistry
【24h】

Developing a Commercially Viable Process for an Active Pharmaceutical Ingredient, Challenges, Myths and Reality in the Art of Process Chemistry

机译:开发活性药物成分的商业可行方法,过程化学领域的挑战,神话和现实

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Process development and optimisation studies for the manufacturing process of N-methyl paroxetine was done by applying Quality by Design (QbD) principles. A normal operating range was defined for each process parameter by technique of design of experiments and knowledge of process chemistry to ensure consistent high quality of advanced intermediate and control of impurities. Initial challenges faced during early process development, were overcome by novel approach using polar aprotic solvents like sulpholane. Finally DMSO was used to improve overall impurity profile significantly.We have demonstrated a “ right first time” approach to avoid failures and bitter surprises during scale up in manufacturing plant.
机译:N-甲基帕罗西汀制造工艺的工艺开发和优化研究是通过应用“设计质量”(QbD)原理完成的。通过实验设计技术和过程化学知识为每个过程参数定义了正常的操作范围,以确保先进的中间体和杂质的控制始终如一的高质量。使用极性非质子传递溶剂(如环丁砜)的新颖方法克服了早期工艺开发过程中面临的最初挑战。最终,DMSO被用来显着改善整体杂质分布。我们展示了一种“正确的第一次”方法,可避免在制造工厂扩大规模时出现故障和令人吃惊的意外。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号